A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy-Reference-Cited by-同舟云学术

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy

Published:2007-01-18 Issue:3 Volume:21 Page:529-534
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Stewart A K,Bergsagel P L,Greipp P R,Dispenzieri A,Gertz M A,Hayman S R,Kumar S,Lacy M Q,Lust J A,Russell S J,Witzig T E,Zeldenrust S R,Dingli D,Reeder C B,Roy V,Kyle R A,Rajkumar S V,Fonseca R

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404516.pdf

Reference86 articles.

1. Kyle RA, Rajkumar SV . Monoclonal gammopathies of undetermined significance. Best Pract Res Clin Haematol 2005; 18: 689–707.

2. Kyle RA, Rajkumar SV . Multiple myeloma. N Engl J Med 2004; 351: 1860–1873.

3. Dispenzieri A, Kyle RA . Multiple myeloma: clinical features and indications for therapy. Best Pract Res Clin Haematol 2005; 18: 553–568.

4. Avet-Loiseau H, Li JY, Morineau N, Facon T, Brigaudeau C, Harousseau JL et al. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome. Blood 1999; 94: 2583–2589.

5. Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA et al. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood 2002; 100: 1417–1424.

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIM44, a Novel Prognostic Marker, Supports the Survival of Proteasome-Resistant Multiple Myeloma Cells;Cells;2024-08-26

2. High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy;American Journal of Hematology;2024-04-13

3. Reduction rate of monoclonal protein as a useful prognostic factor in standard-risk group of newly diagnosed multiple myeloma;World Journal of Clinical Cases;2023-08-26

4. Novel mechanism ofMYCderegulation in Multiple Myeloma;2023-05-22

5. Podocyte-specific Transcription Factors: Could MafB Become a Therapeutic Target for Kidney Disease?;Internal Medicine;2023-01-01